Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapy

JOURNAL ARTICLE published January 2019 in Medical Oncology

Research funded by Bürgermeisterfond der Stadt Wien (15063)

Authors: Markus Kieler | Matthias Unseld | Johann Wojta | Alexandra Kaider | Daniela Bianconi | Svitlana Demyanets | Gerald W. Prager